Natco Pharma (India) Price Prediction
| NATCOPHARM | 1,376 38.05 2.84% |
Oversold Vs Overbought
41
Oversold | Overbought |
Quarterly Earnings Growth 0.835 | Wall Street Target Price 1.3 K | Quarterly Revenue Growth 0.329 |
Using Natco Pharma hype-based prediction, you can estimate the value of Natco Pharma Limited from the perspective of Natco Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Natco Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Natco because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Natco Pharma after-hype prediction price | INR 1366.65 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Natco |
Natco Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Natco Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Natco Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Natco Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Natco Pharma Estimiated After-Hype Price Volatility
In the context of predicting Natco Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Natco Pharma's historical news coverage. Natco Pharma's after-hype downside and upside margins for the prediction period are 1,365 and 1,513, respectively. We have considered Natco Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Natco Pharma is very steady at this time. Analysis and calculation of next after-hype price of Natco Pharma Limited is based on 3 months time horizon.
Natco Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Natco Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Natco Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Natco Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 1.67 | 8.85 | 2.92 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1,376 | 1,367 | 0.64 |
|
Natco Pharma Hype Timeline
Natco Pharma Limited is now traded for 1,376on National Stock Exchange of India of India. The entity has historical hype elasticity of -8.85, and average elasticity to hype of competition of 2.92. Natco is forecasted to decline in value after the next headline, with the price expected to drop to 1366.65. The average volatility of media hype impact on the company price is about 3.02%. The price decline on the next news is expected to be -0.64%, whereas the daily expected return is now at -0.16%. The volatility of related hype on Natco Pharma is about 9.15%, with the expected price after the next announcement by competition of 1,378. About 51.0% of the company outstanding shares are owned by corporate insiders. The book value of Natco Pharma was now reported as 399.14. The company recorded earning per share (EPS) of 108.66. Natco Pharma Limited last dividend was issued on the 27th of November 2024. The entity had 5:1 split on the 26th of November 2015. Assuming the 90 days trading horizon the next forecasted press release will be in about 4 days. Check out Natco Pharma Basic Forecasting Models to cross-verify your projections.Natco Pharma Related Hype Analysis
Having access to credible news sources related to Natco Pharma's direct competition is more important than ever and may enhance your ability to predict Natco Pharma's future price movements. Getting to know how Natco Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Natco Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EMBASSY | EMBASSY OFFICE PARKS | (7.76) | 2 per month | 0.97 | (0.1) | 1.80 | (1.85) | 4.81 | |
| NEWGEN | Newgen Software Technologies | 29.85 | 4 per month | 3.42 | 0.02 | 5.58 | (5.19) | 24.69 | |
| KAMATHOTEL | Kamat Hotels Limited | 6.90 | 1 per month | 1.92 | (0.02) | 4.01 | (3.55) | 24.47 | |
| ARROWGREEN | Arrow Greentech Limited | (43.45) | 2 per month | 2.80 | (0.02) | 7.29 | (5.00) | 15.00 | |
| APOLSINHOT | Apollo Sindoori Hotels | 0.00 | 2 per month | 1.89 | 0.06 | 6.25 | (3.55) | 24.10 | |
| ADVANIHOTR | Advani Hotels Resorts | (0.85) | 1 per month | 0.00 | (0.09) | 4.90 | (3.12) | 11.97 | |
| SASKEN | Sasken Technologies Limited | 143.10 | 3 per month | 1.65 | 0.13 | 6.34 | (3.21) | 18.65 |
Natco Pharma Additional Predictive Modules
Most predictive techniques to examine Natco price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Natco using various technical indicators. When you analyze Natco charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Natco Pharma Predictive Indicators
The successful prediction of Natco Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Natco Pharma Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Natco Pharma based on analysis of Natco Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Natco Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Natco Pharma's related companies.
Story Coverage note for Natco Pharma
The number of cover stories for Natco Pharma depends on current market conditions and Natco Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Natco Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Natco Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Natco Pharma Short Properties
Natco Pharma's future price predictability will typically decrease when Natco Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Natco Pharma Limited often depends not only on the future outlook of the potential Natco Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Natco Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 179.5 M | |
| Cash And Short Term Investments | 13.9 B |
Complementary Tools for Natco Stock analysis
When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |